The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 30, 2018
Filed:
Apr. 01, 2014
Applicant:
Cytocore, Inc., Orlando, FL (US);
Inventors:
Michael E. Jolley, Round Lake, IL (US);
Richard A. Domanik, Libertyville, IL (US);
Assignee:
Medite Cancer Diagnostics, Inc., Orlando, FL (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/58 (2006.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5091 (2013.01); G01N 33/5023 (2013.01); G01N 33/5026 (2013.01); G01N 33/57496 (2013.01); G01N 33/6869 (2013.01); G01N 2333/525 (2013.01); G01N 2333/5428 (2013.01); G01N 2333/715 (2013.01); G01N 2800/50 (2013.01); G01N 2800/7028 (2013.01); G01N 2800/7095 (2013.01);
Abstract
Information on cytokines and cytology obtained from a biological specimen are combined as a method of predicting the risk that dysplasia will progress to cancer. Methods are disclosed herein to augment the evaluation of biological samples from subjects being tested for cancer. In addition to the cell types that are traditionally considered in the morphology-based cytological screening of specimens, methods disclosed herein add evaluations of certain cell types and cytokines that are traditionally discounted or ignored during screening.